1. Diamantis N, Banerji U. Antibody-drug conjugates—an emerging class of cancer treatment. Br J Cancer. 2016;114(2):362-7. doi:10.1038/bjc.2015.435
2. Wu M, Huang S. Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. Mol Clin Oncol. 2017;7(5):738-46. doi:10.3892/mco.2017. 1399
3. Khodos I, Ray SD. Anticancer therapeutic agents. In: Wexler P, ed. Encyclopedia of Toxicology. 4th ed. Elsevier; 2024:549-65. doi:10.1016/B978-0-12-8243 15-2.01116-7
4. Noor U, Ahmed T, Khalid S, Khalid M, Sharif A, Noor I, et al. Nano-drug designing strategies and targeted applications for cancer treatment. Int J Pharm Integr Health Sci. 2023;4(1):68-87. doi:10.56536/ijpihs. v4i1.68
5. Gellerman G. Theranostic targeted drug delivery - new insights into diagnosis and treatment of cancer. Harefuah. 2022;161(1):42-8.
6. Dilnawaz F. Application of Artificial Intelligence for Designing Cancer Nanomedicine. In: Dilnawaz F, Behura AK, eds. Artificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics. Bentham Science Publishers; 2022:4-15. doi:10.2174/9789815050561122010005
7. Masilamani K, Senthilnathan B, Manoyogambiga M, Gowri R, Vigneshwar M, Sathiyasundar R, et al. Techniques and tools for in silico drug design for the development of anticancer drugs. Int J Life Sci Pharma Res. 2023;13(5):P130-P148. doi:10.22376/ijlpr.2023. 13.5.P130-P148
8. Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/ pharmaceutics15071916
9. Wang L, Song Y, Wang H, Zhang X, Wang M, He J, et al. Advances of artificial intelligence in anti-cancer drug design: a review of the past decade. Pharmaceuticals. 2023;16(2):253. doi:10.3390/ph16 020253
10. Niveditha VG, Sindhu V, Kizhakedathil MPJ, Sundari IS, Balasubramaniyan M. Tool and techniques on computer-aided drug design for targeted cancer therapy. In: Malviya R, Sundram S, eds. Targeted Cancer Therapy in Biomedical Engineering. Singapore: Springer; 2023:781-829. doi:10.1007/978-981-19-9786-0_23
11. Kiyonga EM, Kekani LN, Chidziwa TV, Kahwenga KD, Bronkhorst E, Milne M, et al. Nano- and crystal engineering approaches in the development of therapeutic agents for neoplastic diseases. Crystals. 2022;12(7):926. doi:10.3390/cryst12070926
12. Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer Discov. 2021;11(4):900-915. doi:10.1158/2159-8290.CD-21-0090
13. Berkat W. The Impact of Artificial Intelligence in Cancer Research and Treatment. OSF Preprints. 2023. doi:10.31219/osf.io/3fpw5
14. Ali M, Wani SUD, Khan AA, Dey T, Salahuddin M. Current status of artificial intelligence in cancer management: emerging trends, limitations and future outlook. Research Square. 2023. doi:10.21203/rs.3.rs-2724591/v1
15. Choudhuri S, Mallik S, Ghosh B, Si T, Bhadra T, Maulik U, et al. A Review of Computational Learning and IoT Applications to High-Throughput Array-Based Sequencing and Medical Imaging Data in Drug Discovery and Other Health Care Systems. In: De S, Das R, Bhattacharyya S, eds. Applied Smart Health Care Informatics: A Computational Intelligence Perspective. Hoboken, NJ: John Wiley & Sons. 2022: 83-109. doi:10.1002/9781119743187.ch5
16. Choudhuri S, Yendluri M, Poddar S, Li A, Mallick K, Mallik S, et al. Recent Advancements in Computational Drug Design Algorithms through Machine Learning and Optimization. Kinases Phosphatases. 2023;1(2):117-40. doi:10.3390/kinases phosphatases1020008
17. Das KP, J C. Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges. Front Med Technol. 2023;4:1067144. doi:10.3389/ fmedt.2022.1067144
18. Jambhulkar S. Review on Computer-Aided Drug Designing for Targeted Drug Delivery Systems. J Clin Med Res. 2023;5(3):76-82. doi:10.37191/Mapsci-2582-4333-5(3)-134
19. Lin Y. Review of Modern Computer-aided Drug Design Methods. Int J Biol Life Sci. 2022;1(1):47-50. doi:10.54097/ijbls. v1i1.3230
20. Senior AW, Evans R, Jumper J, Kirkpatrick J, Sifre L, Green T, et al. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706-10. doi:10.1038/s41586-019-19 23-7
21. Chen S, Yan K, Liu B. PDB-BRE: A ligand-protein interaction binding residue extractor based on Protein Data Bank. Proteins. 2024;92(1):145-53. doi:10.1002/ prot.26596
22. Muscat S, Errico S, Danani A, Chiti F, Grasso G. Leveraging Machine Learning-Guided Molecular Simulations Coupled with Experimental Data to Decipher Membrane Binding Mechanisms of Aminosterols. bioRxiv. 2024. doi:10.1101/2024.01. 31.578042
23. Nguyen VTD, Nguyen ND, Hy TS. Complex-based Ligand-Binding Proteins Redesign by Equivariant Diffusion-based Generative Models. bioRxiv. 2024. doi:10.1101/2024.04.17.589997
24. Sharma A. Ligand Based Virtual Screening Testing and Analysis for Plasmodium Falciparum. International Journal of Scientific Research in Engineering and Management. 2023;7(10):1-11. doi:10.55041/IJSREM 25981
25. Chandraghatgi R, Ji H-F, Rosen GL, Sokhansanj BA. Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening. J Chem Inf Model. 2024;64(9):3826-40. doi:10.1021/ acs.jcim.4c00234
26. Acharya C, Coop A, Polli JE, MacKerell AD. Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach. Curr. Comput-Aided Drug Des. 2011;7(1):10-22. doi:10.2174/15734091179 3743547
27. Makrynitsa GI, Lykouras M, Spyroulias GA, Matsoukas MT. In silico Drug Design. In: eLS. Chichester: John Wiley & Sons, Ltd. 2018:1-7. doi:10.1002/978047 0015902.a0028112
28. Pujol A, Mosca R, Farrés J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci. 2010;31(3):115-23. doi:10.101 6/j.tips.2009.11.006
29. Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56-68. doi:10.10 38/nrg2918
30. Niazi SK, Mariam Z. Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals. 2024;17(1):22. doi:10.3390/ph17 010022
31. Wang G, Bai Y, Cui J, Zong Z, Gao Y, Zheng Z. Computer-Aided Drug Design Boosts RAS Inhibitor Discovery. Molecules. 2022;27(17):5710. doi:10.339 0/molecules27175710
32. Geronikaki A, Dubey G, Petrou A, Kirubakaran S. Computer-aided drug design: An overview. In: Roy K, ed. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development. London: Academic Press. 2023:39-68. doi:10.1016/B978-0-443-18638-7.00024-4
33. Saudar SS, Surana SS, Shaharwale SS. Computer aided drug designing in development of herbal drug. International Int J Pharmacogn Pharm. 2023;5(1A):41-7. doi:10.33545/27067009.2023.v5.i1a.109
34. Salman MM, Al-Obaidi Z, Kitchen P, Loreto A, Bill RM, Wade-Martins R. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases. Int J Mol Sci. 2021;22(9):4688. doi:10.3390/ ijms22094688
35. Wang YQ, Hu KF, Hu CJ. Application and development of systems biology in computer-aided drug design. Zhongguo Zhong Yao Za Zhi. 2023; 48(11):2868-75. doi:10.19540/j.cnki.cjcmm.2023022 7.601
36. del Carmen Quintal Bojórquez N, Campos MR. Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process. Curr Cancer Drug Targets. 2023;23(5):333-45. doi:10.2174/1568009622666220705104249
37. Nitta N, Sugimura T, Isozaki A, Mikami H, Hiraki K, Sakuma S, et al. Intelligent Image-Activated Cell Sorting. Cell. 2018;175(1):266-276.e213. doi:10.101 6/j.cell.2018.08.028
38. von Lilienfeld OA. Quantum Machine Learning in Chemical Compound Space. Angew Chem Int Ed Engl. 2018;57(16):4164-9. doi:10.1002/anie.201 709686
39. Coley CW, Barzilay R, Jaakkola TS, Green WH, Jensen KF. Prediction of Organic Reaction Outcomes Using Machine Learning. ACS Cent Sci. 2017;3(5): 434-43. doi:10.1021/acscentsci.7b00064
40. Popova M, Isayev O, Tropsha A. Deep reinforcement learning for de novo drug design. Sci Adv. 2018;4(7):eaap7885. doi:10.1126/sciadv. aap7885
41. Reddy D. Data Engineering Challenges in AI Automation. In: 2023 International Conference on Computing, Electronics & Communications Engineering (iCCECE). Piscataway, NJ: IEEE. 2023:107-112. doi:10.1109/iCCECE59400.2023.10238496
42. Lai S. The Applications of Machine Learning to Novel Drug Discovery. Highlights Sci Eng Technol. 2023;76:642-8. doi:10.54097/zz7kz64
43. Zhong F, Xing J, Li X, Liu X, Fu Z, Xiong Z, et al. Artificial intelligence in drug design. Sci China Life Sci. 2018;61(10):1191-1204. doi:10.1007/s11427-018-9342-2
44. Dhudum R, Ganeshpurkar A, Pawar A. Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications. Drugs Drug Candidates. 2024;3(1):148-71. doi:10.3390/ddc3010009
45. Belsare MH, Burusic J. A Conceptual Framework for Impact of Artificial Intelligence and Machine Learning (AIML) in Drug Development Within Pharmaceutical Industry. In: Editors not specified in available sources. Book title: Likely part of a Springer series or proceedings, e.g., "Advances in Intelligent Systems and Computing" or similar based on ISBN pattern. Singapore: Springer. 2023:291-307. doi:10.1007/978-981-99-2909-2_17
46. Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19(1):64. doi:10.118 6/s12874-019-0681-4
47. Farooq M, Shahid MU. Explainable AI and machine learning algorithms to predict treatment failures for patients with cancer. J Clin Oncol. 2023;41 (16_suppl):e13577. doi:10.1200/JCO.2023.41.16_ suppl.e13577
48. Carvalho TFM, Silva JCF, Calil IP, Fontes EPB, Cerqueira FR. Rama: a machine learning approach for ribosomal protein prediction in plants. Sci Rep. 2017;7(1):16273. doi:10.1038/s41598-017-16322-4
49. Manne R. Machine learning techniques in drug discovery and development. Int J Appl Res. 2021;7 (4):21-8. doi:10.22271/allresearch.2021.v7.i4a.8455
50. Polydoros AS, Nalpantidis L. Survey of Model-Based Reinforcement Learning: Applications on Robotics. J Intell Robot Syst. 2017;86(2):153-73. doi:10.1007/ s10846-017-0468-y
51. Quah KH, Quek C, Leedham G. Reinforcement learning combined with a fuzzy adaptive learning control network (FALCON-R) for pattern classification. Pattern Recognit. 2005;38(4):513-26. doi:10.1016/ j.patcog.2004.08.011
52. Kubat M. Induction in multi-label domains. In: Kubat M, ed. An Introduction to Machine Learning. Cham: Springer International Publishing; 2017:251-71. doi:10.1007/978-3-319-63913-0_13
53. Mathivanan JS, Dhayabaran VV, David MR, Karuna Nidhi M, Karuppasamy MP, Thenamudhan SS. Application of Deep Learning Neural Networks in Computer-Aided Drug Discovery: A Review. Curr Bioinform. 2024;19(9):851-8. doi:10.2174/011574 8936276510231123121404
54. Lecler A, Duron L, Soyer P. Revolutionizing radiology with GPT-based models: Current applications, future possibilities and limitations of ChatGPT. Diagn Interv Imaging. 2023;104(6):269-74. doi:10.1016/j.diii. 2023.02.003
55. Zhang S, Fan R, Liu Y, Chen S, Liu Q, Zeng W. Applications of transformer-based language models in bioinformatics: a survey. Bioinform Adv. 2023;3(1): vbad001. doi:10.1093/bioadv/vbad001
56. Liu Z, Roberts RA, Lal-Nag M, Chen X, Huang R, Tong W. AI-based language models powering drug discovery and development. Drug Discov Today. 2021;26(11):2593-607. doi:10.1016/j.drudis.2021.0 6.009
57. Cheng Z, Yan C, Wu FX, Wang J. Drug-Target Interaction Prediction Using Multi-Head Self-Attention and Graph Attention Network. IEEE/ACM Trans Comput Biol Bioinform. 2022;19(4):2208-18. doi:10.1109/TCBB.2021.3077905
58. Ren Q, Li M, Li H, Shen Y. A novel deep learning prediction model for concrete dam displacements using interpretable mixed attention mechanism. Adv Eng Inform. 2021;50:101407. doi:10.1016/j.aei. 2021.101407
59. Lin T, Wang Y, Liu X, Qiu X. A survey of transformers. AI Open. 2022;3:111-132. doi:10.1016/j.aiopen. 2022.10.001
60. Dollar O, Joshi N, Beck DA, Pfaendtner J. Attention-based generative models for de novo molecular design. Chem Sci. 2021;12(24):8362-72. doi:10.1039/ D1SC01050F
61. Kalakoti Y, Yadav S, Sundar D. TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow. ACS Omega. 2022;7(3):2706-17. doi:10. 1021/acsomega.1c05203
62. Lee I, Nam H. Sequence-based prediction of protein binding regions and drug–target interactions. J Cheminform. 2022;14(1):5. doi:10.1186/s13321-022-00584-w
63. Teng S, Yin C, Wang Y, Chen X, Yan Z, Cui L, et al. MolFPG: Multi-level fingerprint-based Graph Transformer for accurate and robust drug toxicity prediction. Comput Biol Med. 2023; 164:106904. doi:10.1016/j.compbiomed.2023.106904
64. Zhou Y, Tan K, Shen X, He Z, Zheng H. A Protein Structure Prediction Approach Leveraging Transformer and CNN Integration. In: 2024 7th International Conference on Advanced Algorithms and Control Engineering (ICAACE). Piscataway, NJ: IEEE; 2024. doi:10.1109/ICAACE61206.2024.10548253
65. Yang F, Wang W, Wang F, Fang Y, Tang D, Huang J, et al. scBERT as a large-scale pretrained deep language model for cell type annotation of single-cell RNA-seq data. Nat Mach Intell. 2022;4(10):852-66. doi:10.1038/s42256-022-00534-z
66. Charoenkwan P, Nantasenamat C, Hasan MM, Manavalan B, Shoombuatong W. BERT4Bitter: a bidirectional encoder representation from transformers (BERT)-based model for improving the prediction of bitter peptides. Bioinformatics. 2021;37(17):2556-62. doi:10.1093/bioinformatics/btab133
67. Raad J, Bugnon LA, Milone DH, Stegmayer G. miRe2e: a full end-to-end deep model based on transformers for prediction of pre-miRNAs. Bioinformatics. 2022;38(5):1191-7. doi:10.1093/ bioinformatics/btab823
68. Castro E, Godavarthi A, Rubinfien J, Givechian K, Bhaskar D, Krishnaswamy S. Transformer-based protein generation with regularized latent space optimization. Nat Mach Intell. 2022;4(10):840-51. doi:10.1038/s42256-022-00532-1
69. Zeng Y, Wei Z, Yu W, Yin R, Yuan Y, Li B, et al. Spatial transcriptomics prediction from histology jointly through Transformer and graph neural networks. Brief Bioinform. 2022;23(5):bbac297. doi:10.1093/bib/bbac297
70. Wang X, Xu X, Tong W, Roberts R, Liu Z. InferBERT: A Transformer-Based Causal Inference Framework for Enhancing Pharmacovigilance. Front Artif Intell. 2021;4:659622. doi:10.3389/frai.2021.659622
71. Fedus W, Rosca M, Lakshminarayanan B, Dai AM, Mohamed S, Goodfellow I. Many paths to equilibrium: GANs do not need to decrease a divergence at every step. arXiv preprint arXiv: 1710.08446. 2017. doi:10.48550/arXiv.1710.08446
72. Lin E, Lin CH, Lane HY. Relevant applications of generative adversarial networks in drug design and discovery: molecular de novo design, dimensionality reduction, and de novo peptide and protein design. Molecules. 2020;25(14):3250. doi:10.3390/molecules 25143250
73. Ge Q, Huang X, Fang S, Guo S, Liu Y, Lin W, et al. Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection. Front Genet. 2020;11:585804. doi:10.3389/fgene.2020.585804
74. Mirza M, Osindero S. Conditional generative adversarial nets. arXiv preprint arXiv:1411.1784. 2014. doi:10.48550/arXiv.1411.1784
75. Kadurin A, Nikolenko S, Khrabrov K, Aliper A, Zhavoronkov A. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico. Mol Pharm. 2017;14(9):3098-104. doi:10.1021/acs.molpharmaceut.7b00346
76. Maziarka Ł, Pocha A, Kaczmarczyk J, Rataj K, Danel T, Warchoł M. Mol-CycleGAN: a generative model for molecular optimization. J Cheminform. 2020; 12(1):2. doi:10.1186/s13321-019-0404-1
77. Kiryu Y. Medical Big Data Analysis Using Machine Learning Algorithms in the Field of Clinical Pharmacy. Yakugaku Zasshi. 2022;142(4):319-26. doi:10.1248/yakushi.21-00178-1
78. Swanson K, Wu E, Zhang A, Alizadeh AA, Zou J. From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell. 2023;186(8):1772-91. doi:10.1016/j. cell.2023.01.035
79. Wu X, Li W, Tu H. Big data and artificial intelligence in cancer research. Trends Cancer. 2024;10(2):147-60. doi:10.1016/j.trecan.2023.10.006
80. Gini G. The impact of artificial intelligence methods on drug design. In: Roy K, ed. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development. London: Academic Press; 2023:89-137. doi:10.1016/B978-0-443-18638-7.00009-8
81. Sahu A, Mishra J, Kushwaha N. Artificial Intelligence (AI) in Drugs and Pharmaceuticals. Comb Chem High Throughput Screen. 2022;25(11):1818-37. doi:10.217 4/1386207325666211207153943
82. Singh R, Maddalwar S, Mishra M. Artificial Intelligence for Computer-Aided Drug Discovery. Drug Res. 2023;73(7):369-77. doi:10.1055/a-2076-3359
83. Ashwin A. An Investigation into the World of Protein-Based Therapeutics-Therapeutic Proteins. J Clin Med Res. 2023;5(3). doi:10.37191/Mapsci-2582-4333-5(3)-135
84. Fajer M, Borrelli K, Abel R, Wang L. Quantitatively Accounting for Protein Reorganization in Computer-Aided Drug Design. J Chem Theory Comput. 2023;19(11):3080-90. doi:10.1021/acs.jctc.3c00009
85. Hameed I, Zubair A, Nazir A, Shahid K, Aimen S, Khan MI, et al. Computer-aided drug design against schizophrenia by targeting SP4. Biomed Lett. 2023;9(1):40-7. doi:10.47262/bl/9.1.20230501
86. Ece A. Computer-aided drug design. BMC Chem. 2023;17(1):26. doi:10.1186/s13065-023-00939-w
87. Ejiofor II, Ekeomodi CC, IlecChukwu AU, Ochiamu MC. CADD for Cancer Therapy: Current and Future Perspective. In: Malviya R, Sundram S, eds. Targeted Cancer Therapy in Biomedical Engineering. Singapore: Springer Nature Singapore; 2023:325-63. doi:10.1007/978-981-19-9786-0_9
88. Poonan P, Agoni C, Ibrahim MAA, Soliman MES. Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective. Protein J. 2021;40(5):601-55. doi:10.1007/s10930-021-10021-w
89. Twite AA, Barnebey A, Brier LW, Barnett B, Jackson WM. Abstract 1525: A novel platform for protein engineering and modification to expand the therapeutic index of anti-tumor therapeutics. Cancer Res. 2023;83(7_Supplement):1525. doi:10.1158/15 38-7445.Am2023-1525
90. Zhu T, Cao S, Su PC, Patel R, Shah D, Chokshi HB, et al. Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis. J Med Chem. 2013;56(17): 6560-72. doi:10.1021/jm301916b
91. Chan HCS, Shan H, Dahoun T, Vogel H, Yuan S. Advancing Drug Discovery via Artificial Intelligence. Trends Pharmacol Sci. 2019;40(8):592-604. doi:10.1016/j.tips.2019.06.004
92. Bassani D, Moro S. Past, present, and future perspectives on computer-aided drug design methodologies. Molecules. 2023;28(9):3906. doi:10.3390/molecules28093906
93. Qian H, Wang B. Exploring the Mechanism of Inula japonica Thunb. against Non-small Cell Lung Cancer using a computer-aided drug design approach. Research Square. 2023. doi:10.21203/rs.3.rs-2970066/v1
94. Shaker B, Ahmad S, Lee J, Jung C, Na D. In silico methods and tools for drug discovery. Comput Biol Med. 2021;137:104851. doi:10.1016/j.compbiomed. 2021.104851
95. Lu W, Zhang R, Jiang H, Zhang H, Luo C. Computer-Aided Drug Design in Epigenetics. Front Chem. 2018;6:57. doi:10.3389/fchem.2018.00057
96. de Souza A, Bittker JA, Lahr DL, Brudz S, Chatwin S, Oprea TI, et al. An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. J Biomol Screen. 2014;19(5):614-27. doi:10.1177/1087057113517139
97. Sivarajah U, Kamal MM, Irani Z, Weerakkody V. Critical analysis of Big Data challenges and analytical methods. J Bus Res. 2017;70:263-86. doi:10.1016/j. jbusres.2016.08.001
98. Pereira DA, Williams JA. Origin and evolution of high throughput screening. Br J Pharmacol. 2007;152(1): 53-61. doi:10.1038/sj.bjp.0707373
99. Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F lix E, et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47(D1): D930-D940. doi:10.1093/nar/gky1075
100. Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49(D1): D1388-D1395. doi:10.1093/nar/gkaa971
101. Frolkis A, Knox C, Lim E, Jewison T, Law V, Hau DD, et al. SMPDB: the Small Molecule Pathway Database. Nucleic Acids Res. 2010;38(suppl_1):D480-D487. doi:10.1093/nar/gkp1002
102. Irwin JJ, Shoichet BK. ZINC− a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177-82. doi:10.1021/ci049714+
103. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007;35(suppl_1): D521-D526. doi:10.1093/nar/gkl923
104. Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 2016;44 (D1):D1045-D1053. doi:10.1093/nar/gkv1072
105. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34 (suppl_1):D668-D672. doi:10.1093/nar/gkj067
106. Sahdeo S, Tomilov A, Komachi K, Iwahashi C, Datta S, Hughes O, et al. High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects. Mitochondrion. 2014;17:116-25. doi:10.1016/j.mito. 2014.07.002
107. Ursu O, Holmes J, Knockel J, Bologa CG, Yang JJ, Mathias SL, Nelson SJ, Oprea TI. DrugCentral: online drug compendium. Nucleic Acids Res. 2017;45(D1): D932-D939. doi:10.1093/nar/gkw993
108. Hecker N, Ahmed J, von Eichborn J, Dunkel M, Macha K, Eckert A, et al. SuperTarget goes quantitative: update on drug–target interactions. Nucleic Acids Res. 2012;40(D1): D1113-D1117. doi:10.1093/nar/gkr912
109. Feng Z, Chen L, Maddula H, Akcan O, Oughtred R, Berman HM, et al. Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics. 2004;20(13):2153-5. doi:10.1093/bioinformatics/ bth214
110. Stark C, Breitkreutz B-J, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34(suppl_1):D535-D539. doi:10.1093/nar/gkj109
111. Xenarios I, Rice DW, Salwinski L, Baron MK, Marcotte EM, Eisenberg D. DIP: the Database of Interacting Proteins. Nucleic Acids Res. 2000;28(1):289-91. doi:10.1093/nar/28.1.289
112. Chen X, Ji ZL, Chen YZ. TTD: Therapeutic Target Database. Nucleic Acids Res. 2002;30(1):412-5. doi:10.1093/nar/30.1.412
113. Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, et al. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics. 2008;9(1):104. doi:10.1186/1471-2105-9-104
114. Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, et al. BioCyc: a genomic and metabolic web portal with multiple omics analytical tools. FASEB J. 2019;33(S1):473.2. doi:10.1096/fasebj. 2019.33.1_supplement.473.2
115. Schomburg I, Chang A, Schomburg D. BRENDA, enzyme data and metabolic information. Nucleic Acids Res. 2002;30(1):47-9. doi:10.1093/nar/30.1.47
116. Croft D, O’Kelly G, Wu G, Haw R, Gillespie M, Matthews L, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39(suppl_1): D691-D697. doi:10.1093/ nar/gkq1018
117. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1): 27-30. doi:10.1093/nar/28.1.27
118. Mattingly CJ, Rosenstein MC, Davis AP, Colby GT, Forrest JN Jr, Boyer JL. The Comparative Toxicogenomics Database: a cross-species resource for building chemical-gene interaction networks. Toxicol Sci. 2006;92(2):587-95. doi:10.1093/toxsci/ kfl008
119. Fowler S, Schnall JG. TOXNET: information on toxicology and environmental health. Am J Nurs. 2014;114(2):61-3. doi:10.1097/01.NAJ.0000443783 .75162.79
120. Ganter B, Snyder RD, Halbert DN, Lee MD. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix® database. Pharmacogenomics. 2006;7(7):1025-44. doi:10.2217/14622416.7.7.1025
121. Nguyen G, Dlugolinsky S, Bob k M, Tran V, L pez Garc a Á, Heredia I, et al. Machine learning and deep learning frameworks and libraries for large-scale data mining: a survey. Artif Intell Rev. 2019;52(1):77-124. doi:10.1007/s10462-018-09679-z
122. Paszke A, Gross S, Massa F, Lerer A, Bradbury J, Chanan G, et al. PyTorch: An imperative style, high-performance deep learning library. Adv Neural Inf Process Syst. 2019;32.
123. Steiner S, Wolf J, Glatzel S, Andreou A, Granda JM, Keenan G, et al. Organic synthesis in a modular robotic system driven by a chemical programming language. Science. 2019;363(6423):eaav2211. doi:10.1126/science. aav2211
124. Coley CW, Barzilay R, Green WH, Jaakkola TS, Jensen KF. Convolutional embedding of attributed molecular graphs for physical property prediction. J Chem Inf Model. 2017;57(8):1757-72. doi:10.10 21/acs.jcim.6b00601
125. G mez-Bombarelli R, Wei JN, Duvenaud D, Hern ndez-Lobato JM, S nchez-Lengeling B, Sheberla D, et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci. 2018;4(2):268-76. doi:10.1021/acscentsci. 7b00572
126. Zhu H. Big data and artificial intelligence modeling for drug discovery. Annu Rev Pharmacol Toxicol. 2020; 60:573-89. doi:10.1146/annurev-pharmtox-010919-023324
127. Mayr A, Klambauer G, Unterthiner T, Hochreiter S. DeepTox: toxicity prediction using deep learning. Front Environ Sci. 2016;3:80. doi:10.3389/fenvs. 2015.00080
128. Ghasemi F, Mehridehnavi A, Fassihi A, P rez-S nchez H. Deep neural network in QSAR studies using deep belief network. Appl Soft Comput. 2018; 62:251-8. doi:10.1016/j.asoc.2017.09.040
129. Wang C, Zhang Y. Improving scoring-docking-screening powers of protein–ligand scoring functions using random forest. J Comput Chem. 2017;38(3):169-77. doi:10.1002/jcc.24667
130. Stork C, Chen Y, cho M, Kirchmair J. Hit Dexter 2.0: machine-learning models for the prediction of frequent hitters. J Chem Inf Model. 2019;59(3):1030-43. doi:10.1021/acs.jcim.8b00677
131. Urban G, Subrahmanya N, Baldi P. Inner and outer recursive neural networks for chemoinformatics applications. J Chem Inf Model. 2018;58(2):207-11. doi:10.1021/acs.jcim.7b00384
132. Jin W, Barzilay R, Jaakkola T. Junction tree variational autoencoder for molecular graph generation. Proc Mach Learn Res. 2018;80:2323-32.
133. Duvenaud DK, Maclaurin D, Iparraguirre J, Bombarell R, Hirzel T, Aspuru-Guzik A, et al. Convolutional networks on graphs for learning molecular fingerprints. Adv Neural Inf Process Syst. 2015;28.
134. Durrant JD, McCammon JA. NNScore 2.0: a neural-network receptor–ligand scoring function. J Chem Inf Model. 2011;51(11):2897-2903. doi:10.1021/ci20 03889
135. Sanchez-Lengeling B, Outeiral C, Guimarães GL, Aspuru-Guzik A. Optimizing distributions over molecular space. An objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC). ChemRxiv. 2017. doi:10.26434/ chemrxiv. 5309668.v3
136. Wójcikowski M, Zielenkiewicz P, Siedlecki P. Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. J Cheminform. 2015;7(1):26. doi:10.1186/s13321-015-0078-2
137. Feinberg EN, Sur D, Wu Z, Husic BE, Mai H, Li Y, Sun S, Yang J, Ramsundar B, Pande VS. PotentialNet for molecular property prediction. ACS Cent Sci. 2018;4(11):1520-30. doi:10.1021/acscentsci.8b00507
138. Awale M, Reymond JL. Polypharmacology Browser PPB2: target prediction combining nearest neighbors with machine learning. J Chem Inf Model. 2019;59(1):10-17. doi:10.1021/acs.jcim.8b00524
139. Cho A. No room for error. Science. 2020;369 (6500):130-3. doi:10.1126/science.369.6500.130
140. Blaschke T, Ar s-Pous J, Chen H, Margreitter C, Tyrchan C, Engkvist O, et al. REINVENT 2.0: an AI tool for de novo drug design. J Chem Inf Model. 2020;60(12):5918-22. doi:10.1021/acs.jcim.0c00915
141. Rosenberg M, Goldblum A. Computational protein design: a novel path to future protein drugs. Curr Pharm Des. 2006;12(31):3973-97. doi:10.2174/13816 1206778743655
142. Hudson WH, Ortlund EA. The structure, function and evolution of proteins that bind DNA and RNA. Nat Rev Mol Cell Biol. 2014;15(11):749-60. doi:10.10 38/nrm3884
143. Shadab S, Alam Khan MT, Neezi NA, Adilina S, Shatabda S. DeepDBP: deep neural networks for identification of DNA-binding proteins. Inform Med Unlocked. 2020;19:100318. doi:10.1016/j.imu.2020. 100318
144. Shi W, Singha M, Pu L, Srivastava G, Ramanujam J, Brylinski M. Graphsite: ligand binding site classification with deep graph learning. Biomolecules. 2022;12(8):1053. doi:10.3390/biom12081053
145. Han LY, Zheng CJ, Xie B, Jia J, Ma XH, Zhu F, et al. Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness. Drug Discov Today. 2007;12(7):304-13. doi:10.1016/j.drudis.2007. 02.015
146. Li Q, Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics. 2007;8(1):353. doi:10.1186/1471-2105-8-353
147. Jamali AA, Ferdousi R, Razzaghi S, Li J, Safdari R, Ebrahimie E. DrugMiner: comparative analysis of machine learning algorithms for prediction of potential druggable proteins. Drug Discov Today. 2016;21(5):718-24. doi:10.1016/j.drudis.2016.01.007
148. Sun T, Lai L, Pei J. Analysis of protein features and machine learning algorithms for prediction of druggable proteins. Quant Biol. 2018;6(4):334-43. doi:10.1007/s40484-018-0157-2
149. Charoenkwan P, Schaduangrat N, Lio’ P, Moni MA, Shoombuatong W, Manavalan B. Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework. iScience. 2022;25(9):104883. doi:10.1016/j.isci. 2022.104883
150. Wang Z, Combs SA, Brand R, Calvo MR, Xu P, Price G, et al. LM-GVP: an extensible sequence and structure informed deep learning framework for protein property prediction. Sci Rep. 2022;12(1):6832. doi:10.1038/s41598-022-10775-y
151. Yu L, Xue L, Liu F, Li Y, Jing R, Luo J. The applications of deep learning algorithms on in silico druggable proteins identification. J Adv Res. 2022;41:219-31. doi:10.1016/j.jare.2022.01.009
152. Chen J, Gu Z, Xu Y, Deng M, Lai L, Pei J. QuoteTarget: a sequence-based transformer protein language model to identify potentially druggable protein targets. Protein Sci. 2023;32(2):e4555. doi:10.1002/pro.4555
153. Saifi I, Bhat BA, Hamdani SS, Bhat UY, Lobato-Tapia CA, Mir MA, et al. Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science. J Biomol Struct Dyn. 2024;42(12):6523-41. doi:10.1080/07391102. 2023.2234039
154. Brown N, Ertl P, Lewis R, Luksch T, Reker D, Schneider N. Artificial intelligence in chemistry and drug design. J Comput Aided Mol Des. 2020;34(7): 709-15. doi:10.1007/s10822-020-00317-x
155. Shirazi A, Tofighi M, Gharavi A, Gomez G. The application of artificial intelligence to cancer research: a comprehensive guide. Technol Cancer Res Treat. 2024;23:15330338241250324. doi:10.1177/153303 38241250324
156. Tran TTV, Surya Wibowo A, Tayara H, Chong KT. Artificial intelligence in drug toxicity prediction: recent advances, challenges, and future perspectives. J Chem Inf Model. 2023;63(9):2628-43. doi:10.1021/ acs.jcim.3c00200
157. Silva JCF, Teixeira RM, Silva FF, Brommonschenkel SH, Fontes EPB. Machine learning approaches and their current application in plant molecular biology: a systematic review. Plant Sci. 2019;284:37-47. doi:10.1016/j.plantsci.2019.03.020
